Autolus Therapeutics PLC (AUTL)
2.94
+0.10
(+3.52%)
USD |
NASDAQ |
Nov 22, 16:00
2.945
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Cash from Investing (Quarterly): -9.589M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -9.589M |
| June 30, 2024 | -0.841M |
| March 31, 2024 | -0.533M |
| December 31, 2023 | -1.477M |
| September 30, 2023 | -1.498M |
| June 30, 2023 | -4.389M |
| March 31, 2023 | -3.622M |
| December 31, 2022 | -0.633M |
| September 30, 2022 | -6.797M |
| June 30, 2022 | -2.64M |
| March 31, 2022 | -0.771M |
| December 31, 2021 | -1.585M |
| Date | Value |
|---|---|
| September 30, 2021 | -3.861M |
| June 30, 2021 | -1.511M |
| March 31, 2021 | -1.90M |
| December 31, 2020 | -5.472M |
| September 30, 2020 | -4.049M |
| June 30, 2020 | -2.523M |
| March 31, 2020 | -2.637M |
| December 31, 2019 | -1.914M |
| September 30, 2019 | -3.781M |
| June 30, 2019 | -5.644M |
| March 31, 2019 | -7.329M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-9.589M
Minimum
Sep 2024
-0.533M
Maximum
Mar 2024
-2.912M
Average
-2.218M
Median
Cash from Investing (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | -66.02M |
| TC BioPharm (Holdings) PLC | -0.0071M |
| Biodexa Pharmaceuticals PLC | -- |
| NuCana PLC | -0.0053M |
| Bicycle Therapeutics PLC | -0.435M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -76.74M |
| Cash from Financing (Quarterly) | 0.185M |
| Free Cash Flow | -205.61M |
| Free Cash Flow Per Share (Quarterly) | -0.3244 |
| Free Cash Flow Yield | -30.13% |